The high-end cellomics market size has grown strongly in recent years. It will grow from $2.9 billion in 2024 to $3.15 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth during the historic period can be attributed to the increasing demand for high-content screening in drug discovery, technological advancements in imaging systems, growth in personalized medicine research, rising investments in academic and pharmaceutical research and development, and the expansion of stem cell and cancer research applications.
The high-end cellomics market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period is expected to result from the integration of AI and machine learning in cell analysis, the growing adoption of 3D cell culture models, the rising demand for automated and high-throughput systems, the increasing focus on regenerative medicine and gene therapy, and the expansion into emerging markets with improving healthcare infrastructure. Major trends during the forecast period include AI-driven image analysis, the integration of high-content screening with CRISPR technologies, the development of 3D cell culture and organoid models, automation and miniaturization of cell-based assays, and cloud-based data management and analytics platforms.
The growing demand for precision medicine is expected to drive the expansion of the high-end cellomics market. Precision medicine is an approach to treatment that customizes therapies for individual patients based on their genetic makeup, lifestyle, and environment. The surge in precision medicine is fueled by advancements in genomics, allowing for personalized treatments that are more effective and have fewer side effects. High-end cellomics uses advanced imaging technologies to provide real-time insights into cellular behavior, helping identify biomarkers and track disease progression. This improves precision medicine by refining personalized treatment plans and enhancing diagnostic accuracy. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based healthcare organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare diseases, up from just six in 2022. As a result, the rising demand for precision medicine is driving growth in the high-end cellomics market.
Companies in the high-end cellomics market are focused on advancing products such as high-content analysis systems to support precision medicine and drug discovery with detailed phenotypic analysis. A high-content analysis (HCA) system is an advanced imaging tool that can simultaneously measure multiple cellular parameters in high-throughput environments. It allows for the analysis of complex biological processes at the cellular level, providing valuable data for drug discovery, toxicity testing, and personalized medicine. For example, in February 2024, Yokogawa Electric Corporation, a Japan-based company specializing in electrical engineering and software, launched the CellVoyager CQ3000. This benchtop high-content analysis system captures high-definition 3D images of live cell cultures quickly, allowing for detailed and efficient evaluation of cellular reactions and drug effects. It features Yokogawa’s proprietary confocal scanner unit with dual spinning-disk technology to minimize phototoxicity, high-precision temperature control for stable long-term live cell imaging, and options for deep learning analysis. When combined with the CellPathfinder image analysis software, it facilitates advanced data analysis, supporting drug discovery, regenerative medicine research, and basic biological studies.
In January 2023, Bruker Corporation, a U.S.-based provider of advanced fluorescence microscopy imaging products, acquired ACQUIFER Imaging GmbH for an undisclosed sum. This acquisition strengthens Bruker’s bioimaging portfolio by integrating ACQUIFER's flagship HIVE data management systems, which offer high-performance computing, deep learning, and scalable data storage solutions. ACQUIFER Imaging GmbH, based in Germany, specializes in big-data management solutions for bioimaging and high-content microscopy.
Major players in the high end cellomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company (BD), GE Healthcare, Agilent Technologies Inc., Sartorius AG, Bio-Rad Laboratories, Yokogawa Electric Corporation, Bruker Corporation, Carl Zeiss AG, Miltenyi Biotec GmbH, Leica Microsystems GmbH, 10x Genomics, Promega Corporation, Abcam plc, Molecular Devices LLC, NanoString Technologies, Sphere Fluidics, Nikon Instruments Inc., and Tecan Group Ltd.
North America was the largest region in the high-end cellomics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in high-end cellomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the high-end cellomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
High-end cellomics involves state-of-the-art, automated technologies that combine high-content imaging with advanced data analytics to study cellular behavior at the single-cell level. These platforms facilitate high-throughput screening and deliver quantitative insights into cell morphology, molecular expression, and functional responses. They are particularly effective for identifying subtle cellular changes in response to drugs or environmental factors.
The primary product types in high-end cellomics include instruments, reagents and consumables, and software and services. Instruments are sophisticated scientific tools designed for precise measurement, imaging, and analysis of cells, tissues, and biological samples in both research and clinical applications. These tools incorporate various technologies such as microscopy, flow cytometry, single-cell genomics, mass spectrometry, next-generation sequencing, and more, serving a range of applications such as drug discovery, cancer research, neuroscience, stem cell research, regenerative medicine, personalized medicine, and others. They are utilized by diverse end-users, including biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations, and more.
The high end cellomics market research report is one of a series of new reports that provides high end cellomics market statistics, including the high end cellomics industry global market size, regional shares, competitors with the high end cellomics market share, detailed high end cellomics market segments, market trends, opportunities, and any further data you may need to thrive in the high end cellomics industry. This high end cellomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The high-end cellomics market consists of revenues earned by entities by providing services such as single-cell analysis, target identification and validation, and customization. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-end cellomics market also includes sales of assay kits, cell imaging plates, live-cell imaging chambers, and artificial intelligence (AI)-based analytics modules. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified.)
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The high-end cellomics market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period is expected to result from the integration of AI and machine learning in cell analysis, the growing adoption of 3D cell culture models, the rising demand for automated and high-throughput systems, the increasing focus on regenerative medicine and gene therapy, and the expansion into emerging markets with improving healthcare infrastructure. Major trends during the forecast period include AI-driven image analysis, the integration of high-content screening with CRISPR technologies, the development of 3D cell culture and organoid models, automation and miniaturization of cell-based assays, and cloud-based data management and analytics platforms.
The growing demand for precision medicine is expected to drive the expansion of the high-end cellomics market. Precision medicine is an approach to treatment that customizes therapies for individual patients based on their genetic makeup, lifestyle, and environment. The surge in precision medicine is fueled by advancements in genomics, allowing for personalized treatments that are more effective and have fewer side effects. High-end cellomics uses advanced imaging technologies to provide real-time insights into cellular behavior, helping identify biomarkers and track disease progression. This improves precision medicine by refining personalized treatment plans and enhancing diagnostic accuracy. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based healthcare organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare diseases, up from just six in 2022. As a result, the rising demand for precision medicine is driving growth in the high-end cellomics market.
Companies in the high-end cellomics market are focused on advancing products such as high-content analysis systems to support precision medicine and drug discovery with detailed phenotypic analysis. A high-content analysis (HCA) system is an advanced imaging tool that can simultaneously measure multiple cellular parameters in high-throughput environments. It allows for the analysis of complex biological processes at the cellular level, providing valuable data for drug discovery, toxicity testing, and personalized medicine. For example, in February 2024, Yokogawa Electric Corporation, a Japan-based company specializing in electrical engineering and software, launched the CellVoyager CQ3000. This benchtop high-content analysis system captures high-definition 3D images of live cell cultures quickly, allowing for detailed and efficient evaluation of cellular reactions and drug effects. It features Yokogawa’s proprietary confocal scanner unit with dual spinning-disk technology to minimize phototoxicity, high-precision temperature control for stable long-term live cell imaging, and options for deep learning analysis. When combined with the CellPathfinder image analysis software, it facilitates advanced data analysis, supporting drug discovery, regenerative medicine research, and basic biological studies.
In January 2023, Bruker Corporation, a U.S.-based provider of advanced fluorescence microscopy imaging products, acquired ACQUIFER Imaging GmbH for an undisclosed sum. This acquisition strengthens Bruker’s bioimaging portfolio by integrating ACQUIFER's flagship HIVE data management systems, which offer high-performance computing, deep learning, and scalable data storage solutions. ACQUIFER Imaging GmbH, based in Germany, specializes in big-data management solutions for bioimaging and high-content microscopy.
Major players in the high end cellomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company (BD), GE Healthcare, Agilent Technologies Inc., Sartorius AG, Bio-Rad Laboratories, Yokogawa Electric Corporation, Bruker Corporation, Carl Zeiss AG, Miltenyi Biotec GmbH, Leica Microsystems GmbH, 10x Genomics, Promega Corporation, Abcam plc, Molecular Devices LLC, NanoString Technologies, Sphere Fluidics, Nikon Instruments Inc., and Tecan Group Ltd.
North America was the largest region in the high-end cellomics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in high-end cellomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the high-end cellomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
High-end cellomics involves state-of-the-art, automated technologies that combine high-content imaging with advanced data analytics to study cellular behavior at the single-cell level. These platforms facilitate high-throughput screening and deliver quantitative insights into cell morphology, molecular expression, and functional responses. They are particularly effective for identifying subtle cellular changes in response to drugs or environmental factors.
The primary product types in high-end cellomics include instruments, reagents and consumables, and software and services. Instruments are sophisticated scientific tools designed for precise measurement, imaging, and analysis of cells, tissues, and biological samples in both research and clinical applications. These tools incorporate various technologies such as microscopy, flow cytometry, single-cell genomics, mass spectrometry, next-generation sequencing, and more, serving a range of applications such as drug discovery, cancer research, neuroscience, stem cell research, regenerative medicine, personalized medicine, and others. They are utilized by diverse end-users, including biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations, and more.
The high end cellomics market research report is one of a series of new reports that provides high end cellomics market statistics, including the high end cellomics industry global market size, regional shares, competitors with the high end cellomics market share, detailed high end cellomics market segments, market trends, opportunities, and any further data you may need to thrive in the high end cellomics industry. This high end cellomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The high-end cellomics market consists of revenues earned by entities by providing services such as single-cell analysis, target identification and validation, and customization. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-end cellomics market also includes sales of assay kits, cell imaging plates, live-cell imaging chambers, and artificial intelligence (AI)-based analytics modules. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified.)
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. High End Cellomics Market Characteristics3. High End Cellomics Market Trends And Strategies4. High End Cellomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market32. Global High End Cellomics Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The High End Cellomics Market34. Recent Developments In The High End Cellomics Market
5. Global High End Cellomics Growth Analysis And Strategic Analysis Framework
6. High End Cellomics Market Segmentation
7. High End Cellomics Market Regional And Country Analysis
8. Asia-Pacific High End Cellomics Market
9. China High End Cellomics Market
10. India High End Cellomics Market
11. Japan High End Cellomics Market
12. Australia High End Cellomics Market
13. Indonesia High End Cellomics Market
14. South Korea High End Cellomics Market
15. Western Europe High End Cellomics Market
16. UK High End Cellomics Market
17. Germany High End Cellomics Market
18. France High End Cellomics Market
19. Italy High End Cellomics Market
20. Spain High End Cellomics Market
21. Eastern Europe High End Cellomics Market
22. Russia High End Cellomics Market
23. North America High End Cellomics Market
24. USA High End Cellomics Market
25. Canada High End Cellomics Market
26. South America High End Cellomics Market
27. Brazil High End Cellomics Market
28. Middle East High End Cellomics Market
29. Africa High End Cellomics Market
30. High End Cellomics Market Competitive Landscape And Company Profiles
31. High End Cellomics Market Other Major And Innovative Companies
35. High End Cellomics Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
High End Cellomics Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on high end cellomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for high end cellomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The high end cellomics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Type: Instruments; Reagents And Consumables; Software And Services2) By Technology: Microscopy; Flow Cytometry; Single-Cell Genomics; Mass Spectrometry; Next Generation Sequencing; Other Technologies
3) By Application: Drug Discovery; Cancer Research; Neuroscience; Stem Cell Research And Regenerative Medicine; Personalized Medicine; Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies; Hospitals And Diagnostic Laboratories; Contract Research Organizations; Other End-Users
Subsegments:
1) By Instruments: High-Content Screening Systems; Flow Cytometers; Confocal Microscopes; Automated Microscopy Systems; Image Analysis Workstations; Robotic Cell Handling Systems2) By Reagents And Consumables: Fluorescent Dyes And Probes; Cell Staining Kits; Cell Culture Reagents; Assay Kits; Microplates; Slide And Cover Glasses; Fixatives And Buffers
3) By Software And Services: Image Analysis Software; Data Management And Integration Tools; Artificial Intelligence (AI)-Based Predictive Analytics Software; Cloud-Based Data Storage Solutions; Technical Support And Maintenance Services; Custom Assay Development Services; Training And User Support Programs
Key Companies Profiled: Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company (BD); GE Healthcare; Agilent Technologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton, Dickinson and Company (BD)
- GE Healthcare
- Agilent Technologies Inc.
- Sartorius AG
- Bio-Rad Laboratories
- Yokogawa Electric Corporation
- Bruker Corporation
- Carl Zeiss AG
- Miltenyi Biotec GmbH
- Leica Microsystems GmbH
- 10x Genomics
- Promega Corporation
- Abcam plc
- Molecular Devices LLC
- NanoString Technologies
- Sphere Fluidics
- Nikon Instruments Inc.
- Tecan Group Ltd.
